Pancreatic Cancer

We combine evidence-based medicine with compassionate, personalized care to diagnose and treat people with pancreatic cancer. Our team of specialists is at the forefront of groundbreaking research, studying promising new treatments and pioneering methods for detecting pancreatic cancer earlier, when it’s most treatable.

We create an individualized treatment plan for you, drawing upon our expertise in endoscopic and surgical treatments as well as medical therapies.

Clinical Trials and Research Studies

Phase 1

A Phase I Study of Immune Checkpoint inhibition (anti-CTLA4 and/or anti-PD-L1) in Combination with Radiation Therapy in Patients with Unresectable and Non-metastatic Pancreatic Cancer

Phase 2

A Phase II Multicenter Single-Arm Study of Oral Ceritinib in Adult Patients With ALK and ROS1 Activated Gastrointestinal Malignancies

Phase 2

Perioperative Therapy for Resectable Pancreatic Adenocarcinoma and Borderline Resectable Pancreatic Adenocarcinoma With Molecular Correlates

Phase 3

A Phase 3 Randomized Double-Blind Placebo-Controlled Multicenter Study of PEGPH20 in Combination With nab-Paclitaxel and Gemcitabine in Subjects with Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma